Anti-SARS-CoV-2 Spike RBD [2838]
- SKU:
- IVMB0230
- Product Type:
- Recombinant Monoclonal Antibody
- Clone:
- 2838
- Protein:
- SARS-CoV-2 RBD
- Synonyms:
- COV2-2838, SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Antibody
- Isotype:
- Human IgG1
- Reactivity:
- Virus
Frequently bought together:
Description
system_update_altDatasheet
Product Name: | Anti-SARS-CoV-2 Spike RBD [2838] |
Product Code: | IVMB0230 |
Clone: | 2838 |
Protein: | SARS-CoV-2 RBD |
Product Type: | Recombinant Monoclonal Antibody |
Synonyms: | COV2-2838, SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Antibody |
Isotype: | Human IgG1 |
Reactivity: | SARS-CoV-2 ? Virus |
Immunogen: | Sequenced from human survivors of COVID-19 (SARS-CoV-2) |
Applications: | ELISA |
Formulation: | This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
Applications: | ELISA |
Recommended Usage: | ELISA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. |
Reactivity: | SARS-CoV-2 ? Virus |
Specificity: | Anti-SARS-CoV-2 Spike RBD, clone 2838, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD). |
Antigen Distribution: | The spike RBD is expressed on the surface of SARS-CoV-2. |
Immunogen: | Sequenced from human survivors of COVID-19 (SARS-CoV-2) |
Concentration: | ≥ 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC |
Formulation: | This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
Protein: | SARS-CoV-2 RBD |
Research Area: | COVID-19, Viral |